Tydes Retatrutide
As of 9 Aug 2026, Finnrick has published 9 independent lab tests of Retatrutide from Tydes: 8 passed and 1 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 30 Apr 2025. The current Finnrick rating for Tydes Retatrutide is 82%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 30 Apr 2025 | Pass | Certificate oteqcul |
| 30 Apr 2025 | Pass | Certificate jz18uqx |
| 25 Apr 2025 | Pass | Certificate mjbjtcc |
| 20 Mar 2025 | Pass | Certificate zfdcx76 |
| 28 Feb 2025 | Fail | Certificate awr50vg |
| 28 Feb 2025 | Pass | Certificate 0of1jda |
| 27 Feb 2025 | Pass | Certificate lwtgi0h |
| 23 Jan 2025 | Pass | Certificate zcwmf7o |
| 17 Dec 2024 | Pass | Certificate v0bo12m |